Medicamen Biotech’s Bhiwadi Formulation facility gets final EU GMP Certification

11 Sep 2024 Evaluate

Medicamen Biotech’s General Tablets and Liquid Orals Formulation facility located at Phase IV, Industrial Area, Bhiwadi has received the final approval (EU GMP Certification) on September 11, 2024 from the Inspection Department, Division of Production & Distribution Control, National Organisation for Medicines, GREECE.

Medicamen Biotech is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets.

Medicamen Biotech Share Price

362.35 -4.55 (-1.24%)
06-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1760.15
Dr. Reddys Lab 1255.95
Cipla 1530.35
Zydus Lifesciences 931.25
Lupin 2151.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×